Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference
Integra LifeSciences (Nasdaq:IART) announced that chief financial officer Lea Knight will present at the 2026 Jefferies Global Healthcare Conference on June 3, 2026, at 10:30am ET.
Rhea-AI Summary
Integra LifeSciences (Nasdaq:IART) announced that chief financial officer Lea Knight will present at the 2026 Jefferies Global Healthcare Conference on June 3, 2026, at 10:30am ET.
A live webcast of the presentation will be available on the company’s investor relations website under Events & Presentations.
Positive
- None.
Negative
- None.
Key Figures
- Conference date
- June 3, 2026
- Jefferies Global Healthcare Conference presentation date
- Presentation time
- 10:30am ET
- Scheduled start time of Jefferies conference presentation
Historical Context
-
Announcement of CFO presentation at BofA 2026 Health Care Conference.
-
Appointment of Stuart M. Essig as CEO and creation of chief commercial officer role.
-
Q1 2026 results with revenue growth and raised adjusted EPS guidance.
-
Scheduling of Q1 2026 results release and investor conference call.
-
Presentation plan for new real-world PriMatrix evidence across multiple indications.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will present at the 2026 Jefferies Global Healthcare Conference on June 3, 2026 at 10:30am ET.
A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.
About Integra LifeSciences
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
Integra LifeSciences Holdings Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.